-+ 0.00%
-+ 0.00%
-+ 0.00%

SCTbio And Fortrea Collaborate To Streamline Development, Accelerate Timelines And Bring Advanced Therapies To Patients Faster

Benzinga·12/04/2025 12:03:51
Listen to the news

SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based products, and Fortrea, a leading global contract research organization (CRO), today announced a strategic collaboration agreement between the two companies. This partnership aims to streamline development, accelerate timelines and bring advanced therapies to patients faster.

This collaboration represents a forward-looking model for how CDMOs and CROs can collaborate to deliver synchronized solutions that help to de-risk programs, streamline planning, expedite study setup and optimize cost-efficiency across the entire development lifecycle. According to The American Society of Cell & Gene Therapy, there are more than 4,400 gene, cell and RNA therapies currently in development.